To investigate the effect of diabetes mellitus (DM) on the postoperative clinical outcomes and perioperative bleeding volume in patients with primary total knee arthroplasty. Clinical data of 49 patients with osteoarthritis underwent primary total knee arthroplasty (TKA) were collected and retrospectively analyzed from October 2015 and September 2016. Patients were set to two groups with (A) or without DM (B). Data were compared between 2 groups, including postoperative hemoglobin, hematocrit (Hct), Hb, dominant blood loss, hidden blood loss, theoretical total blood loss, range of joint motion, VAS score, increasing rate of circumference length above 10 cm of the knee, HSS score, the operation time and hospitalization days. The results showed that the Hb and Hct of A group was significantly less than the B group (P<0.05). The dominant blood loss, the hidden blood loss and theoretical total blood loss of A group was significantly higher than B group (P<0.05). The hospitalization days of A group was significantly longer than B group (P<0.05). The VAS score and the increasing rate of circumference length above 10 cm of the knee of A group was significantly higher than B group at 3 days (P<0.05). The patients were all followed up 12 weeks. The HSS score of A group was significantly lower than B group at 4 weeks (P<0.05). There was no significant difference in the HSS score between 2 groups at 12 weeks after operation (P>0.05). The prosthesis was in good position, without loosening, subsidence, or osteolysis. In general, patients with DM got TKA have a higher bleeding and longer hospitalization days. DM acts as an adverse impact on recent functional recovery after TKA.
Published in | Journal of Surgery (Volume 5, Issue 2) |
DOI | 10.11648/j.js.20170502.15 |
Page(s) | 33-36 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2017. Published by Science Publishing Group |
Knee Osteoarthritis, Diabetes Mellitus, Total Knee Arthroplasty, Blood Loss
[1] | Glyn-Jones, S., A. J. Palmer, R. Agricola, A. J. Price, T. L. Vincent, H. Weinans, and A. J. Carr, Osteoarthritis. Lancet, 2015, 386(9991):376-87. |
[2] | Chang, A. H., J. S. Chmiel, O. Almagor, A. Guermazi, P. V. Prasad, K. C. Moisio, L. Belisle, Y. Zhang, K. Hayes, and L. Sharma, Association of baseline knee sagittal dynamic joint stiffness during gait and 2-year patellofemoral cartilage damage worsening in knee osteoarthritis. Osteoarthritis Cartilage, 2017, 25(2):242-248. |
[3] | King, K. B. and A. K. Rosenthal, The adverse effects of diabetes on osteoarthritis: update on clinical evidence and molecular mechanisms. Osteoarthritis Cartilage, 2015, 23(6):841-50. |
[4] | Kharroubi, A. T. and H. M. Darwish, Diabetes mellitus: The epidemic of the century. World J Diabetes, 2015, 6(6):850-67. |
[5] | Courties, A., O. Gualillo, F. Berenbaum, and J. Sellam, Metabolic stress-induced joint inflammation and osteoarthritis. Osteoarthritis Cartilage, 2015, 23(11):1955-65. |
[6] | Nieves-Plaza, M., L. E. Castro-Santana, Y. M. Font, A. M. Mayor, and L. M. Vila, Association of hand or knee osteoarthritis with diabetes mellitus in a population of Hispanics from Puerto Rico. J Clin Rheumatol, 2013, 19(1):1-6. |
[7] | Schett, G., A. Kleyer, C. Perricone, E. Sahinbegovic, A. Iagnocco, J. Zwerina, R. Lorenzini, F. Aschenbrenner, F. Berenbaum, M. A. D'Agostino, J. Willeit, and S. Kiechl, Diabetes is an independent predictor for severe osteoarthritis: results from a longitudinal cohort study. Diabetes Care, 2013, 36(2):403-9. |
[8] | Yang, Z., H. Liu, X. Xie, Z. Tan, T. Qin, and P. Kang, The influence of diabetes mellitus on the post-operative outcome of elective primary total knee replacement: a systematic review and meta-analysis. Bone Joint J, 2014, 96-B(12):1637-43. |
[9] | Amusat, N., L. Beaupre, G. S. Jhangri, S. L. Pohar, S. Simpson, S. Warren, and C. A. Jones, Diabetes that impacts on routine activities predicts slower recovery after total knee arthroplasty: an observational study. J Physiother, 2014, 60(4):217-23. |
[10] | Bolognesi, M. P., M. H. Marchant, Jr., N. A. Viens, C. Cook, R. Pietrobon, and T. P. Vail, The impact of diabetes on perioperative patient outcomes after total hip and total knee arthroplasty in the United States. J Arthroplasty, 2008, 23(6 Suppl 1):92-8. |
[11] | Viens, N. A., K. T. Hug, M. H. Marchant, C. Cook, T. P. Vail, and M. P. Bolognesi, Role of diabetes type in perioperative outcomes after hip and knee arthroplasty in the United States. J Surg Orthop Adv, 2012, 21(4):253-60. |
[12] | King, K. B., T. W. Findley, A. E. Williams, and A. L. Bucknell, Veterans with diabetes receive arthroplasty more frequently and at a younger age. Clin Orthop Relat Res, 2013, 471(9):3049-54. |
[13] | Robertson, F., J. Geddes, D. Ridley, G. McLeod, and K. Cheng, Patients with Type 2 diabetes mellitus have a worse functional outcome post knee arthroplasty: a matched cohort study. Knee, 2012, 19(4):286-9. |
[14] | Meding, J. B., K. Reddleman, M. E. Keating, A. Klay, M. A. Ritter, P. M. Faris, and M. E. Berend, Total knee replacement in patients with diabetes mellitus. Clin Orthop Relat Res, 2003(416):208-16. |
APA Style
Houge Hou, Huajun Wang. (2017). Diabetes Mellitus Related to Clinical Outcomes and Postoperative Bleeding of Total Knee Arthroplasty. Journal of Surgery, 5(2), 33-36. https://doi.org/10.11648/j.js.20170502.15
ACS Style
Houge Hou; Huajun Wang. Diabetes Mellitus Related to Clinical Outcomes and Postoperative Bleeding of Total Knee Arthroplasty. J. Surg. 2017, 5(2), 33-36. doi: 10.11648/j.js.20170502.15
AMA Style
Houge Hou, Huajun Wang. Diabetes Mellitus Related to Clinical Outcomes and Postoperative Bleeding of Total Knee Arthroplasty. J Surg. 2017;5(2):33-36. doi: 10.11648/j.js.20170502.15
@article{10.11648/j.js.20170502.15, author = {Houge Hou and Huajun Wang}, title = {Diabetes Mellitus Related to Clinical Outcomes and Postoperative Bleeding of Total Knee Arthroplasty}, journal = {Journal of Surgery}, volume = {5}, number = {2}, pages = {33-36}, doi = {10.11648/j.js.20170502.15}, url = {https://doi.org/10.11648/j.js.20170502.15}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.js.20170502.15}, abstract = {To investigate the effect of diabetes mellitus (DM) on the postoperative clinical outcomes and perioperative bleeding volume in patients with primary total knee arthroplasty. Clinical data of 49 patients with osteoarthritis underwent primary total knee arthroplasty (TKA) were collected and retrospectively analyzed from October 2015 and September 2016. Patients were set to two groups with (A) or without DM (B). Data were compared between 2 groups, including postoperative hemoglobin, hematocrit (Hct), Hb, dominant blood loss, hidden blood loss, theoretical total blood loss, range of joint motion, VAS score, increasing rate of circumference length above 10 cm of the knee, HSS score, the operation time and hospitalization days. The results showed that the Hb and Hct of A group was significantly less than the B group (P<0.05). The dominant blood loss, the hidden blood loss and theoretical total blood loss of A group was significantly higher than B group (P<0.05). The hospitalization days of A group was significantly longer than B group (P<0.05). The VAS score and the increasing rate of circumference length above 10 cm of the knee of A group was significantly higher than B group at 3 days (P<0.05). The patients were all followed up 12 weeks. The HSS score of A group was significantly lower than B group at 4 weeks (P<0.05). There was no significant difference in the HSS score between 2 groups at 12 weeks after operation (P>0.05). The prosthesis was in good position, without loosening, subsidence, or osteolysis. In general, patients with DM got TKA have a higher bleeding and longer hospitalization days. DM acts as an adverse impact on recent functional recovery after TKA.}, year = {2017} }
TY - JOUR T1 - Diabetes Mellitus Related to Clinical Outcomes and Postoperative Bleeding of Total Knee Arthroplasty AU - Houge Hou AU - Huajun Wang Y1 - 2017/04/29 PY - 2017 N1 - https://doi.org/10.11648/j.js.20170502.15 DO - 10.11648/j.js.20170502.15 T2 - Journal of Surgery JF - Journal of Surgery JO - Journal of Surgery SP - 33 EP - 36 PB - Science Publishing Group SN - 2330-0930 UR - https://doi.org/10.11648/j.js.20170502.15 AB - To investigate the effect of diabetes mellitus (DM) on the postoperative clinical outcomes and perioperative bleeding volume in patients with primary total knee arthroplasty. Clinical data of 49 patients with osteoarthritis underwent primary total knee arthroplasty (TKA) were collected and retrospectively analyzed from October 2015 and September 2016. Patients were set to two groups with (A) or without DM (B). Data were compared between 2 groups, including postoperative hemoglobin, hematocrit (Hct), Hb, dominant blood loss, hidden blood loss, theoretical total blood loss, range of joint motion, VAS score, increasing rate of circumference length above 10 cm of the knee, HSS score, the operation time and hospitalization days. The results showed that the Hb and Hct of A group was significantly less than the B group (P<0.05). The dominant blood loss, the hidden blood loss and theoretical total blood loss of A group was significantly higher than B group (P<0.05). The hospitalization days of A group was significantly longer than B group (P<0.05). The VAS score and the increasing rate of circumference length above 10 cm of the knee of A group was significantly higher than B group at 3 days (P<0.05). The patients were all followed up 12 weeks. The HSS score of A group was significantly lower than B group at 4 weeks (P<0.05). There was no significant difference in the HSS score between 2 groups at 12 weeks after operation (P>0.05). The prosthesis was in good position, without loosening, subsidence, or osteolysis. In general, patients with DM got TKA have a higher bleeding and longer hospitalization days. DM acts as an adverse impact on recent functional recovery after TKA. VL - 5 IS - 2 ER -